L. Mitchell

COVID‐19 infection in patients on anti‐complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience

P. Muus, P. Hillmen, M. Griffin, 2020, British journal of haematology.

hemoglobinuria : sustained efficacy and improved survival Long-term treatment with eculizumab in paroxysmal nocturnal

W. Gregory, S. Richards, M. Cullen, 2011 .

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

W. Gregory, S. Richards, M. Cullen, 2010, Blood.

Treated Follicular Lymphoma, Recurrent Invasive Pneumococcal Disease, Nonresponsiveness to Vaccination, and a Unique Pneumococcus

G. Edwards, C. McGoldrick, D. Inverarity, 2012, Case reports in hematology.

Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI‐deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry

S. Richards, M. Cullen, P. Hillmen, 2020, British journal of haematology.

Screening haematology patients for carbapenem-resistant Klebsiella pneumoniae

Elizabeth Kilgour, D. Inverarity, L. Mitchell, 2014, Journal of infection prevention.